Early and massive death of myoblasts transplanted into skeletal muscle: Responsible factors and potential solutions

Current Opinion in Organ Transplantation

Volumn 12, Issue 6, 2007, Pages 664-667

  Bouchentouf, Manaf ^a   Skuk, Daniel ^a   Tremblay, Jacques P ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b RC 9300 ^*  (Canada)

Author keywords

Apoptosis; Dystrophy; Myoblast; Skeletal muscle; Transplantation

Indexed keywords

COMPLEMENT COMPONENT C3; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TUMOR NECROSIS FACTOR ALPHA;

ANOIKIS; CELL ADHESION; CELL DEATH; CELL SURVIVAL; CELL TRANSPLANTATION; DNA MODIFICATION; HUMAN; HYPOXIA; INFLAMMATION; MUSCLE ISCHEMIA; MUSCLE TRANSPLANTATION; MYOBLAST; MYOPATHY; NATURAL KILLER CELL; NONHUMAN; PHYSICAL STRESS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SKELETAL MUSCLE;

EID: 36249021362     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3282f19f20     Document Type: Review

References (33)

1. Skuk D, Roy B, Goulet M, et al. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther 2004; 9:475-482.
2. Skuk D, Furling D, Bouchard JP, et al. Transplantation of human myoblasts in SCID mice as a potential muscularmodel for myotonic dystrophy. J Neuropathol Exp Neurol 1999; 58:921-931.
3. Chachques JC, Cattadori B, Herreros J, et al. Treatment of heart failure with autologous skeletal myoblasts. Herz 2002; 27:570-578.
4. Skuk D, Tremblay JP. Complement deposition and cell death after myoblast transplantation. Cell Transplant 1998; 7:427-434.
5. Maurel A, Azarnoush K, Sabbah L, et al. Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium? Transplantation 2005; 80:660-665.
6. Huard J, Acsadi G, Jani A, et al. Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 1994; 5:949-958.
7. Fan Y, Maley M, Beilharz M, et al. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 1996; 19:853-860.
8. Merly F, Huard C, Asselin I, et al. Anti-inflammatory effect of transforming growth factor-beta1 in myoblast transplantation. Transplantation 1998; 65:793-799.
9. Guerette B, Skuk D, Celestin F, et al. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol 1997; 159:2522-2531.
10. Qu Z, Balkir L, van Deutekom JC, et al. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998; 142:1257-1267.
11. Rando TA, Blau HM. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 1994; 125:1275-1287.
12. Beauchamp JR, Morgan JE, Pagel CN, et al. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 1999; 144:1113-1122.
13. Skuk D, Caron NJ, Goulet M, et al. Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J Neuropathol Exp Neurol 2003; 62:951-967.
14. Guerette B, Asselin I, Skuk D, et al. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant 1997; 6:101-107.
15. Sammels LM, Bosio E, Fragall CT, et al. Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy. Transplantation 2004; 77:1790-1797.
16. Skuk D, Caron N, Goulet M, et al. Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplant 2002; 11:671-681.
17. Chazaud B, Hittinger L, Sonnet C, et al. Endoventricular porcine autologous myoblast transplantation can be successfully achieved with minor mechanical cell damage. Cardiovasc Res 2003; 58:444-450.
18. Baines CP, Molkentin JD. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 2005; 38:47-62.
19. Grossmann J. Molecular mechanisms of 'detachment-induced apoptosis - anoikis'. Apoptosis 2002; 7:247-260.
20. Jan Y, Matter M, Pai JT, et al. A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell 2004; 116:751-762.
21. Fujio Y, Mitsuuchi Y, Testa JR, et al. Activation of Akt2 inhibits anoikis and apoptosis induced by myogenic differentiation. Cell Death Differ 2001; 8:1207-1212.
22. Martin SS, Vuori K. Regulation of Bcl-2 proteins during anoikis and amorphosis. Biochim Biophys Acta 2004; 1692:145-157.
23. Bouchentouf M, Benabdallah BF, Rousseau J, et al. Induction of anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways. Am J Transplant 2007; 7:1491-1505. In this manuscript, the authors have clearly demonstrated for the first time that skeletal myoblasts are sensitive to adhesion blockade. They have demonstrated that these cells die by anoikis both in vitro and in vivo. They have also shown myoblast survival can be improved by specific inhibition of FADD and Bit-1 proapoptotic proteins or by overexpression of Bcl-2 antiapoptotic protein.
24. Skuk DTJ. Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell transplantation strategies. Transplantation (in press).
25. Skuk D, Goulet M, Roy B, et al. First test of a 'high-density injection' protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscul Disord 2007; 17:38-46. The authors reported procedures done and results observed in a severely affected 26-year-old patient with Duchenne muscular dystrophy who received myoblast intramuscular allotransplantations by a high-density injection protocol, 18 months following the transplantation. The results show that between 27.5% and 34.5% of fibers in injected muscle expressed dystrophin. It is the first time that an adult patient with Duchenne muscular dystrophy received high-density injection of myoblasts.
26. Skuk D, Goulet M, Tremblay JP. Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant 2006; 15:659-663.
27. Fan Y, Beilharz MW, Grounds MD. A potential alternative strategy for myoblast transfer therapy: the use of sliced muscle grafts. Cell Transplant 1996; 5:421-429.
28. Sonnet C, Lafuste P, Arnold L, et al. Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems. J Cell Sci 2006; 119 (Pt 12):2497-2507.
29. -/- mice. J Histochem Cytochem 2001; 49:989-1001.
30. Bouchentouf M, Benabdallah BF, Tremblay JP. Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 2004; 77:1349-1356.
31. Suzuki K, Smolenski RT, Jayakumar J, et al. Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 2000; 102 (19 Suppl 3):III216-III221.
32. Parsell DA, Taulien J, Lindquist S. The role of heat-shock proteins in thermotolerance. Phil Trans R Soc Lond B Biol Sci 1993; 339:279-285; discussion 285-6.
33. Hiratsuka M, Yano M, Mora BN, et al. Heat shock pretreatment protects pulmonary isografts from subsequent ischemia-reperfusion injury. J Heart Lung Transplant 1998; 17:1238-1246.